Article Information
History
- March 17, 2021.
Article Versions
- You are currently viewing Version 1 of this article (March 17, 2021 - 04:24).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Laura Fabbri1,2,3,
- Samuel Moss1,2,
- Fasihul Khan1,2,
- Wenjie Chi4,
- Jun Xia5,
- Karen Robinson6,
- Alan Smyth2,7,
- Gisli Jenkins1,2,3 and
- Iain Stewart1,2,3,*
- 1Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK
- 2Nottingham Biomedical Research Centre, National Institute for Health Research, UK
- 3National Heart and Lung Institute, Imperial College London, London, UK
- 4Systematic Review Solutions Ltd, Ingenuity Centre, Nottingham, UK
- 5Institute of Mental Health, University of Nottingham, Nottingham, UK
- 6Department of Medicine, School of Medicine, Johns Hopkins University, US
- 7Division of Child Health, Obstetrics & Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK
- ↵*Correspondence to: Dr Iain Stewart, iain.stewart{at}imperial.ac.uk
Posted March 17, 2021.
Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: A systematic review and meta-analysis
